Stanley A. Lang

1.6k total citations
52 papers, 1.2k citations indexed

About

Stanley A. Lang is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Stanley A. Lang has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Organic Chemistry, 20 papers in Molecular Biology and 8 papers in Infectious Diseases. Recurrent topics in Stanley A. Lang's work include Synthesis and Biological Evaluation (11 papers), Synthesis and biological activity (8 papers) and Cancer therapeutics and mechanisms (6 papers). Stanley A. Lang is often cited by papers focused on Synthesis and Biological Evaluation (11 papers), Synthesis and biological activity (8 papers) and Cancer therapeutics and mechanisms (6 papers). Stanley A. Lang collaborates with scholars based in United States, Russia and China. Stanley A. Lang's co-authors include Yang‐I Lin, Jonathan D. Bloom, Nikolay Savchuk, Martin DiGrandi, Konstantin V. Balakin, Andrey A. Ivashchenko, Michael Ostrander, K. A. WATANABE, Donald Armstrong and Bruce Polsky and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Stanley A. Lang

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanley A. Lang United States 18 577 362 169 133 118 52 1.2k
Lee F. Kuyper United States 23 584 1.0× 705 1.9× 87 0.5× 190 1.4× 139 1.2× 34 1.4k
Yun He United States 21 918 1.6× 529 1.5× 168 1.0× 112 0.8× 133 1.1× 52 1.5k
Philip S. Jones United Kingdom 24 883 1.5× 505 1.4× 72 0.4× 135 1.0× 83 0.7× 63 1.7k
Michael Cory United States 20 679 1.2× 949 2.6× 154 0.9× 564 4.2× 116 1.0× 50 1.7k
Hans De Winter Belgium 21 354 0.6× 657 1.8× 82 0.5× 199 1.5× 92 0.8× 94 1.6k
Beat Weidmann Switzerland 18 879 1.5× 533 1.5× 106 0.6× 141 1.1× 56 0.5× 25 1.3k
Wayne J. Brouillette United States 25 476 0.8× 1.1k 3.0× 314 1.9× 128 1.0× 53 0.4× 78 1.6k
Eric Buisine France 19 457 0.8× 674 1.9× 145 0.9× 142 1.1× 81 0.7× 23 1.3k
Daniel P. Becker United States 21 543 0.9× 769 2.1× 360 2.1× 237 1.8× 134 1.1× 78 1.7k
Keith G. Watson Australia 20 556 1.0× 467 1.3× 217 1.3× 76 0.6× 105 0.9× 53 1.2k

Countries citing papers authored by Stanley A. Lang

Since Specialization
Citations

This map shows the geographic impact of Stanley A. Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley A. Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley A. Lang more than expected).

Fields of papers citing papers by Stanley A. Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley A. Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley A. Lang. The network helps show where Stanley A. Lang may publish in the future.

Co-authorship network of co-authors of Stanley A. Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley A. Lang. A scholar is included among the top collaborators of Stanley A. Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley A. Lang. Stanley A. Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barawkar, Dinesh A., Subrata Chakravarty, Matthew Allan, et al.. (2006). Discovery of 3-hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles as potent MEK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(15). 3975–3980. 32 indexed citations
2.
Barawkar, Dinesh A., Subrata Chakravarty, Andreas Maderna, et al.. (2006). Identification of isothiazole-4-carboxamidines derivatives as a novel class of allosteric MEK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5561–5566. 20 indexed citations
3.
Gunić, Esmir, Yung‐hyo Koh, Ilia Korboukh, et al.. (2006). Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 16(17). 4444–4449. 95 indexed citations
4.
Smith, Kenneth L., Vicky C. H. Lai, Brett J. Prigaro, et al.. (2004). Synthesis of new 2′-β-C-methyl related triciribine analogues as anti-HCV agents. Bioorganic & Medicinal Chemistry Letters. 14(13). 3517–3520. 10 indexed citations
5.
Bloom, Jonathan D., Russell G. Dushin, Kevin J. Curran, et al.. (2004). Thiourea inhibitors of herpes viruses. Part 2: N-Benzyl-N′-arylthiourea inhibitors of CMV. Bioorganic & Medicinal Chemistry Letters. 14(13). 3401–3406. 54 indexed citations
6.
Bloom, Jonathan D., Martin DiGrandi, Russell G. Dushin, et al.. (2003). Thiourea inhibitors of herpes viruses. part 1: bis-(aryl)thiourea inhibitors of CMV. Bioorganic & Medicinal Chemistry Letters. 13(17). 2929–2932. 41 indexed citations
7.
Grandi, Martin J. Di, Kevin J. Curran, Ellen Z. Baum, et al.. (2003). Pyrimido[1,2-b]-1,2,4,5-tetrazin-6-ones as HCMV protease inhibitors: a new class of heterocycles with flavin-like redox properties. Bioorganic & Medicinal Chemistry Letters. 13(20). 3483–3486. 13 indexed citations
8.
Lang, Stanley A., et al.. (2002). Classification scheme for the design of serine protease targeted compound libraries. Journal of Computer-Aided Molecular Design. 16(11). 803–807. 6 indexed citations
9.
Nikitenko, Antonia A., et al.. (1992). A novel reagent for regioselective cleavage of 2,3-epoxyalcohols by fluoride - a synthesis of 3-fluoro-293-dideoxy-d-erythro-pentose.. Tetrahedron Letters. 33(47). 7087–7088. 16 indexed citations
10.
Xiao, Wei, et al.. (1989). Synthesis and In Vitro Antibacterial Activity of Some 1-(Difluoromethoxyphenyl)quinolone-3-carboxylic Acids. Journal of Pharmaceutical Sciences. 78(7). 585–588. 4 indexed citations
12.
Krishnan, Rehna & Stanley A. Lang. (1988). Synthesis and Antibacterial Activity of 6-Difluoromethoxy-7-piperazinyl-3-quinolinecarboxylic Acid Derivatives. Journal of Pharmaceutical Sciences. 77(5). 458–460. 4 indexed citations
13.
Lang, Stanley A., et al.. (1986). Antibacterial Activity of 6, 8-Disubstituted-Quinolone-3-Carboxylic Acids. Journal of Pharmaceutical Sciences. 75(12). 1185–1187. 6 indexed citations
14.
Lang, Stanley A., et al.. (1986). Synthesis of aminoquinolone derivatives. Journal of Heterocyclic Chemistry. 23(6). 1801–1804. 9 indexed citations
15.
Angier, Robert B., R. V. Citarella, P. F. FABIO, et al.. (1984). ChemInform Abstract: SYNTHESIS OF 3,6‐BIS(AMINOALKOXY)ACRIDINES AND THEIR EFFECT ON THE IMMUNE SYSTEM. Chemischer Informationsdienst. 15(18). 5 indexed citations
17.
Lin, Yang‐I, et al.. (1979). Aldehyde Syntheses. Study of the preparation of 9,10-anthracenedicarboxaldehyde. The Journal of Organic Chemistry. 44(25). 4701–4703. 17 indexed citations
18.
Lin, Yang‐I, et al.. (1978). A new method for the synthesis of fused 3‐amino‐s‐triazole ring systems. Journal of Heterocyclic Chemistry. 15(2). 311–312. 8 indexed citations
19.
Paquette, Leo A., et al.. (1972). Unsaturated heterocyclic systems. LXXXV. Benzoannelation effects on azocine reactivity. Chemical and polarographic reduction of several mono-, di-, and tribenzomethoxyazocines. Journal of the American Chemical Society. 94(14). 4907–4915. 9 indexed citations
20.
Paquette, Leo A., et al.. (1972). Hydration of hexamethyl (Dewar benzene) oxide. Stereochemical aspects of the resulting rearrangement. Tetrahedron Letters. 13(31). 3137–3140. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026